BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7605915)

  • 1. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex.
    Mori F; Lai CC; Fusi F; Giacobini E
    Neuroreport; 1995 Mar; 6(4):633-6. PubMed ID: 7605915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex.
    Giacobini E; Mori F; Lai CC
    Ann N Y Acad Sci; 1996 Jan; 777():393-8. PubMed ID: 8624119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
    De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
    Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
    Cuadra G; Summers K; Giacobini E
    J Pharmacol Exp Ther; 1994 Jul; 270(1):277-84. PubMed ID: 7913496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
    Cuadra G; Giacobini E
    J Pharmacol Exp Ther; 1995 Oct; 275(1):228-36. PubMed ID: 7562554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heptyl-physostigmine enhances basal forebrain control of cortical cerebral blood flow.
    Linville DG; Giacobini E; Arnerić SP
    J Neurosci Res; 1992 Mar; 31(3):573-7. PubMed ID: 1640506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex.
    Messamore E; Warpman U; Ogane N; Giacobini E
    Neuropharmacology; 1993 Aug; 32(8):745-50. PubMed ID: 8413838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo.
    Cuadra G; Giacobini E
    J Pharmacol Exp Ther; 1995 Apr; 273(1):230-40. PubMed ID: 7714770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.
    Haroutunian V; Greig N; Pei XF; Utsuki T; Gluck R; Acevedo LD; Davis KL; Wallace WC
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):161-8. PubMed ID: 9191090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated secretion of beta-amyloid precursor protein in rat brain.
    Farber SA; Nitsch RM; Schulz JG; Wurtman RJ
    J Neurosci; 1995 Nov; 15(11):7442-51. PubMed ID: 7472496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.
    Lahiri DK; Farlow MR; Nurnberger JI; Greig NH
    Ann N Y Acad Sci; 1997 Sep; 826():416-21. PubMed ID: 9329715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal patch delivery of acetylcholinesterase inhibitors.
    Moriearty PL; Thornton SL; Becker RE
    Methods Find Exp Clin Pharmacol; 1993; 15(6):407-12. PubMed ID: 8231460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition.
    Messamore E; Warpman U; Williams E; Giacobini E
    Neurosci Lett; 1993 Aug; 158(2):205-8. PubMed ID: 8233096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.
    Lahiri DK; Farlow MR
    J Mol Neurosci; 1996; 7(1):41-9. PubMed ID: 8835781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
    Hinz VC; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):331-7. PubMed ID: 9139239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.
    Giacobini E; Zhu X D; Williams E; Sherman KA
    Neuropharmacology; 1996 Feb; 35(2):205-11. PubMed ID: 8734490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.
    Szerb JC; Somogyi GT
    Nat New Biol; 1973 Jan; 241(108):121-2. PubMed ID: 4512454
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro.
    Pakaski M; Rakonczay Z; Kasa P
    Neurochem Int; 2001 Mar; 38(3):219-26. PubMed ID: 11099780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine.
    Beach TG; Kuo YM; Schwab C; Walker DG; Roher AE
    Neurosci Lett; 2001 Sep; 310(1):21-4. PubMed ID: 11524148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain.
    Qiu Y; Chen HZ; Wu XJ; Jin ZJ
    Eur J Pharmacol; 2003 May; 468(1):1-8. PubMed ID: 12729836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.